Calls Now Open
2026 Harrington Scholar-Innovator and 2026 Harrington Prize
Mark Edbrooke, PhD is an independent scientific consultant, who brings broad experience in pharmaceutical research and development. During his 25 year tenure at GlaxoSmithKline, he ran a transnational functional genomics department, and then set up and led GSK’s therapeutic oligonucleotide unit. He then joined AstraZeneca’s Oncology Division for 3 years, working with Moderna and others. He currently has a portfolio of clients including UK- and European-based universities, UK- and US-based investment companies, and small biotechs across the globe including being Head of Translational Research at Argonaute RNA Ltd., and on the SAB for Deep Genomics.